ARTICLE | Clinical News
Hollis-Eden preclinical data
February 2, 2009 8:00 AM UTC
In rat models of obesity induced metabolic disorders, oral Triolex produced complete normalization of fasting and fed blood glucose levels, improved insulin sensitivity, reduced concentrations of pyru...